Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observationRam B. Singh, Manoj Saxena, Puneet Kumar et al.|International Journal of Clinical Pharmacology and Therapeutics|2020Cited by 8